Conference Coverage

New agent builds bone bigger, faster

Publish date: July 17, 2014

 

AT ICE/ENDO 2014

References

These phase II studies were funded by Radius Health.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Atypical hip fracture risk low with bisphosphonates, but be aware
MDedge Family Medicine
Nonmelanoma skin cancer linked to increased fracture risk in postmenopausal women
MDedge Family Medicine
Denosumab's benefits persist through 8 years
MDedge Family Medicine
Effects of IV bisphosphonates last 2-3 years in children
MDedge Family Medicine
Effects of IV bisphosphonates last 2-3 years in children
MDedge Family Medicine
Monitor elderly for bone loss after gastric bypass
MDedge Family Medicine
Monitor elderly for bone loss after gastric bypass
MDedge Family Medicine
Hyponatremia linked to osteoporosis, fragility fractures
MDedge Family Medicine
Meta-analysis finds limited bone loss with low-dose glucocorticoids
MDedge Family Medicine
Fractures increased with two diabetes drugs
MDedge Family Medicine